; (ii) how the incident was assigned within the Agency; and (iii) whether an individual affected by the incident is provided an opportunity to appeal the credible alternative explanation. (C) For each priority case of an anomalous health incident determined to be largely consistent with the definition of anomalous health incident established by the National Academy of Sciences and for which the Agency does not have a credible alternative explanation, a detailed description of such case. (3) Anomalous health incident sensors (A) A list of all types of sensors that the Agency has developed or deployed with respect to reports of anomalous health incidents, including, for each type of sensor, the deployment location, the date and the duration of the employment of such type of sensor, and, if applicable, the reason for removal. (B) A list of entities to which the Agency has provided unrestricted access to data associated with anomalous health incidents. (C) A list of requests for support the Agency has received from elements of the Federal Government regarding sensor development, testing, or deployment, and a description of the support provided in each case. (D) A description of all emitter signatures obtained by sensors associated with anomalous health incidents in Agency holdings since 2016, including— (i) the identification of any of such emitters that the Agency prioritizes as a threat; and (ii) an explanation of such prioritization. (d) Additional submissions Concurrent with the submission of the report required by subsection (b), the Director of the Central Intelligence Agency shall submit to the congressional intelligence committees— (1) a template of each form required to apply for the Expanded Care Program, including with respect to payments for a qualifying injury or a qualifying injury to the brain; (2) copies of internal guidance used by the Agency to adjudicate claims for the Expanded Care Program, including with respect to payments for a qualifying injury to the brain